Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2017/11/010443
CTRI/2017/11/010443
Completed
Phase 4

Comparative study on Efficacy and safety profile of Amitriptyline and Fluoxetine in patients with depression

svasanth0 sites80 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
svasanth
Enrollment
80
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
November 11, 2016
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
svasanth

Eligibility Criteria

Inclusion Criteria

  • •1\.19years â?? 60 years of age both sex
  • •2\.newly diagnosed patients with clinical depression (moderate to severe ) according to ICD 10 criteria
  • •3\. Major depressive disorder patients.

Exclusion Criteria

  • •1\.Less than 19 years
  • •2\. more than 60 years.
  • •3\.Pregnant and Lactating mothers.
  • •4\.Patients with h/o Cardiac , Hepatic and renal disease ,Co morbid illness and terminal illness.
  • •Known case of Pulmonary Tuberculosis, HIV/AIDS, Leprosy, Hypothyroidism.
  • •Patients with history of hypersensitive reaction to Amitriptyline and Fluoxetine.
  • •Patients on any other investigational drugs.
  • •Depression with psychosis, bipolar depression .

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
To compare the efficacy and safety profile of topical minoxidil versus low dose oral minoxidil in patients with hairfall and hair thinning due to androgenetic alopecia in tertiary care teaching hospital,Haldwani,Uttarakhand.Health Condition 1: L649- Androgenic alopecia, unspecified
CTRI/2024/03/063477Dr Sally Rajkumari
Not yet recruiting
Not Applicable
A study to see the effects of two drugs metronidazole and tacrolimus steroid induced rosacea.Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
CTRI/2020/06/025629Government medical collage Haldwani
Completed
Not Applicable
The comparative study of efficacy and safety in the treatment with mixed-type insulin to combined therapy with long-acting insulin analog and GLP-1 recepter agonist in type 2 DM.Type 2 Diabetes Mellitus
JPRN-UMIN000016628Hyogo College Of Medicine Division of Diabetes,Endocrinology and Metabolism,Department of Internal Medicine10
Recruiting
Not Applicable
Safety of Etoricoxib and Piroxicam oral drugs in Osteoarthritis patients at Rama hospital KanpurHealth Condition 1: M179- Osteoarthritis of knee, unspecified
CTRI/2022/12/047816PRINC BGHEA
Recruiting
Phase 4
A study to evaluate cost effectiveness and safety of pain killers with and without acid reducing drugs in patients having pain in knee.
CTRI/2013/05/003618DrMehwishmajeed94